Related references
Note: Only part of the references are listed.New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser
Y. M. Cho et al.
DIABETOLOGIA (2011)
The Dying-Back Phenomenon of Motor Neurons in ALS
Michal Dadon-Nachum et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis
L. M. Duffy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Albert C. Ludolph et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus
A. Jawaid et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
John M. Lincecum et al.
NATURE GENETICS (2010)
Inflammation in ALS and SMA: Sorting out the good from the evil
Dimitra Papadimitriou et al.
NEUROBIOLOGY OF DISEASE (2010)
Metformin Inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway
Suman Rice et al.
ENDOCRINOLOGY (2009)
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Hristelina Ilieva et al.
JOURNAL OF CELL BIOLOGY (2009)
Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis
Narender Nath et al.
JOURNAL OF IMMUNOLOGY (2009)
No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS
Alan Gill et al.
PLOS ONE (2009)
Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
Yaomin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
Albert C. Ludolph et al.
Therapeutic Advances in Neurological Disorders (2009)
Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis
Wade S. Parkhouse et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Design, power, and interpretation of studies in the standard murine model of ALS
Sean Scott et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications
Mauro Cozzolino et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis
J. Hegedus et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice
Chan-Il Choi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression
Paul S. Sharp et al.
NEUROBIOLOGY OF DISEASE (2008)
Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
L. Dupuis et al.
NEUROLOGY (2008)
Time course of preferential motor unit loss in the SODIG93A mouse model of amyotrophic lateral sclerosis
J. Hegedus et al.
NEUROBIOLOGY OF DISEASE (2007)
Metformin therapy in a transgenic mouse model of Huntington's disease
Thong C. Ma et al.
NEUROSCIENCE LETTERS (2007)
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials
Alberto Ferri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS
Thomas W. Gould et al.
JOURNAL OF NEUROSCIENCE (2006)
Neuroprotective agents for clinical trials in ALS - A systematic assessment
B. J. Traynor et al.
NEUROLOGY (2006)
Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells
K Isoda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Activation of AMP-activated protein kinase reduces hyperglycemia-Induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells
D Kukidome et al.
DIABETES (2006)
Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells
N Ouslimani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
The effect of peripheral nerve injury on disease progression in the SOD1 ((G93A)) mouse model of amyotrophic lateral sclerosis
PS Sharp et al.
NEUROSCIENCE (2005)
Thiazolidinediones, like metformin, inhibit respiratory complex I -: A common mechanism contributing to their antidiabetic actions?
B Brunmair et al.
DIABETES (2004)
Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin
P Dandona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Ovariectomy and 17β-estradiol modulate disease progression of a mouse model of ALS
GJ Groeneveld et al.
BRAIN RESEARCH (2004)
Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS
GM Alexander et al.
MOLECULAR BRAIN RESEARCH (2004)
Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS
CY Zheng et al.
ANNALS OF NEUROLOGY (2004)
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
M Azzouz et al.
NATURE (2004)
Experimental therapeutics in transgenic mouse models of Huntington's disease
MF Beal et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Metformin has direct effects on human ovarian steroidogenesis
R Mansfield et al.
FERTILITY AND STERILITY (2003)
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
SA Hawley et al.
DIABETES (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Metformin reverses fatty liver disease in obese, leptin-deficient mice
HZ Lin et al.
NATURE MEDICINE (2000)
Share Paper
